The new Covid vaccines from Pfizer and Moderna began to roll out last week after the CDC recommended them to all Americans ages six months and up.
Pfizer (PFE) gets marketing authorization in the EU for Litfulo to treat adults and adolescent patients aged 12 years and older with severe alopecia areata.

Pfizer Stock: Bear vs. Bull

10:07am, Tuesday, 19'th Sep 2023
Pfizer is planning to acquire businesses and assets to power its growth. It'll be fighting against falling coronavirus medicine sales and also generic drugs.
Looking for dividend stocks yielding 3% or more might seem pretty specific. Remember, though, the logic behind investing in underrated stocks is straightforward: Buy low and sell high in order to see
Moderna (MRNA) was the worst-performing stock in the S&P 500 as shares dropped 9% after Pfizer CFO David Denton said the outlook for vaccine rates this year got a significant "haircut." Pfizer (PFE) s
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, Oct
Pfizer expects 24% vaccination rate in the United States for this fall with its COVID vaccines, chief financial officer David Denton said at a conference on Monday.
Pfizer's $43 billion bid for Seagen will be decided by EU antitrust regulators by Oct. 19, a regulatory filing showed on Friday.
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
It's been a rough year to invest in pharma stocks. The industry is adjusting to a sector that is less reliant on Covid-19 vaccines and is adapting to the effects of inflation as well as pressure from
Chief executives from a wide array of U.S. companies will meet White House Chief of Staff Jeff Zients on Thursday to discuss refugee resettlement and sponsorship programs, a White House official said.
Updated Covid vaccines from Pfizer and Moderna will soon be administered at pharmacies, and many other locations across the U.S.
Towards the end of 2021, Nvidia (NASDAQ: NVDA ) stock was trading at $300. NVDA stock corrected to lows of $108 by October 2022 before skyrocketing by more than 200% for year-to-date.
It's been a difficult time for biotechnology stocks. After a boom during the Covid-19 pandemic, the entire sector appears to have been abandoned by investors.
CDC Director Mandy Cohen still has to sign off on the panel's recommendation before the new Pfizer and Moderna Covid vaccines become available nationwide.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE